| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-10 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-10 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-10 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-10 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-09 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-09 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-09 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-09 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.21 | 5e-09 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-09 |